Financial Year |
March 31 2023 |
Monetary Funds |
818,929,438.84 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
2,637,110.43 |
Accounts Receivable |
62,622,145.74 |
Advances to Suppliers |
2,746,578.89 |
Other Receivables |
143,033,948.93 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
5,370,090,382.09 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
209,475,907.04 |
Total Current Assets |
6,609,535,511.96 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
616,782,997.79 |
Investment Properties |
-- |
Fixed Assetes |
5,227,137.70 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,612,747.19 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
114,967.40 |
Deferred Income Tax Assets |
419,653,193.76 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
1,079,953,528.82 |
Total Assets |
7,689,489,040.78 |
Short-Term Loans |
1,835,932.64 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
503,688,036.30 |
Accounts Received In Advance |
6,857.21 |
Employee Compensation Payable |
24,958,535.10 |
Taxes Payable |
353,463,411.90 |
Interest Payable |
-- |
Dividend Payable |
982,913.96 |
Other payables |
103,508,062.10 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
247,197,049.48 |
Sub-Total of Current Liabilities |
5,462,899,026.31 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
5,850,660.62 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
5,850,660.62 |
Total Liabilities |
5,468,749,686.93 |
Paid-In Capital(Or Share Stock) |
1,617,272,234.00 |
Capital Surplus |
309,244,146.02 |
Surplus Reserve |
64,940,033.27 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
172,353,469.84 |
Minority Stockholder's Interest |
56,929,470.72 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,163,809,883.13 |
Owner's Equity(Stockholder's Equity) |
2,220,739,353.85 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
7,689,489,040.78 |